Improved post-marketing safety surveillance of quadrivalent inactivated influenza vaccine in Mexico using a computerized, SMS-based follow-up system-Reference-Cited by-同舟云学术

Improved post-marketing safety surveillance of quadrivalent inactivated influenza vaccine in Mexico using a computerized, SMS-based follow-up system

Published:2021-08-18 Issue: Volume: Page:1-4
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Betancourt-Cravioto Miguel¹,Cervantes-Powell Patricia²^ORCID,Tapia-Conyer Roberto³,Ledlie Shaleesa⁴,Gandhi-Banga Sonja⁴

Affiliation:

1. Sociedad Mexicana de Salud Pública, CDMX, Mexico

2. Medical Department, Sanofi Pasteur, CDMX, México

3. Family Medicine, School of Medicine. National Autonomous University of Mexico, Mexico City, Mexico

4. Epidemiology and Benefit-Risk Department, Sanofi Pasteur, Toronto, Ontario, Canada

Funder

Sanofi Pasteur

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2021.1935170

Reference20 articles.

1. WHO. Influenza (Seasonal). [accessed 2020 May 12]. https://www.who.int/en/news-room/fact-sheets/detail/influenza-(seasonal).

2. WHO. WHO recommendations on the composition of influenza virus vaccines. [accessed 2020 May 12]. https://www.who.int/influenza/vaccines/virus/recommendations/en/.

3. The vaccine adverse event reporting system (VAERS)

4. Active surveillance for adverse events following immunization

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced safety surveillance of GSK's quadrivalent seasonal influenza vaccine in Germany and Spain (2021/2022 season) using an electronic patient‐reported outcome system for vaccine safety remote monitoring;Influenza and Other Respiratory Viruses;2023-03